As AD progresses, microglia increase their sensitivity to IL-3 by expressing IL-3Rα; the IL-3 induces extensive programming of the microglia transcriptome, deploys immune and motor responses, and promotes microglial immune activation, and the aggregation and clearance of Aβ and tau aggregates [154]. The gene discussed is MAPT; the disease is Alzheimer disease.